313 related articles for article (PubMed ID: 16361714)
1. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports.
Hasegawa T; Suga Y; Mizoguchi M; Muramatsu S; Mizuno Y; Ogawa H; Kubo K; Kuroyanagi Y
J Dermatol; 2005 Sep; 32(9):715-20. PubMed ID: 16361714
[TBL] [Abstract][Full Text] [Related]
2. Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.
Taniguchi T; Amoh Y; Tanabe K; Katsuoka K; Kuroyanagi Y
J Artif Organs; 2012 Mar; 15(1):77-82. PubMed ID: 21861088
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers.
Yamada N; Uchinuma E; Kuroyanagi Y
J Artif Organs; 2012 Jun; 15(2):193-9. PubMed ID: 22138722
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection.
Moroi Y; Fujita S; Fukagawa S; Mashino T; Goto T; Masuda T; Urabe K; Kubo K; Matsui H; Kagawa S; Kuroyanagi Y; Furue M
Eur J Dermatol; 2004; 14(3):172-6. PubMed ID: 15246944
[TBL] [Abstract][Full Text] [Related]
5. Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.
Toyozawa S; Yamamoto Y; Nishide T; Kishioka A; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
Dermatol Online J; 2008 Nov; 14(11):17. PubMed ID: 19094855
[TBL] [Abstract][Full Text] [Related]
6. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute.
Kashiwa N; Ito O; Ueda T; Kubo K; Matsui H; Kuroyanagi Y
Artif Organs; 2004 May; 28(5):444-50. PubMed ID: 15113338
[TBL] [Abstract][Full Text] [Related]
7. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.
Kuroyanagi Y; Yamada N; Yamashita R; Uchinuma E
Artif Organs; 2001 Mar; 25(3):180-6. PubMed ID: 11284884
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test.
Tanaka M; Nakakita N; Kuroyanagi Y
J Biomater Sci Polym Ed; 1999; 10(4):433-53. PubMed ID: 10227466
[TBL] [Abstract][Full Text] [Related]
9. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers.
Yonezawa M; Tanizaki H; Inoguchi N; Ishida M; Katoh M; Tachibana T; Miyachi Y; Kubo K; Kuroyanagi Y
Int J Dermatol; 2007 Jan; 46(1):36-42. PubMed ID: 17214717
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg.
Yamada N; Uchinuma E; Kuroyanagi Y
J Artif Organs; 2008; 11(2):100-3. PubMed ID: 18604614
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of intractable skin ulcers using allogeneic cultured dermal substitutes in patients with systemic lupus erythematosus.
Toyozawa S; Yamamoto Y; Kishioka A; Yonei N; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
Eur J Dermatol; 2009; 19(6):594-6. PubMed ID: 19666399
[TBL] [Abstract][Full Text] [Related]
12. Autologous full-thickness skin substitute for healing chronic wounds.
Gibbs S; van den Hoogenband HM; Kirtschig G; Richters CD; Spiekstra SW; Breetveld M; Scheper RJ; de Boer EM
Br J Dermatol; 2006 Aug; 155(2):267-74. PubMed ID: 16882162
[TBL] [Abstract][Full Text] [Related]
13. Establishment of banking system for allogeneic cultured dermal substitute.
Kuroyanagi Y; Kubo K; Matsui H; Kim HJ; Numari S; Mabuchi Y; Kagawa S
Artif Organs; 2004 Jan; 28(1):13-21. PubMed ID: 14720283
[TBL] [Abstract][Full Text] [Related]
14. Skin grafting for the treatment of chronic leg ulcers - a systematic review in evidence-based medicine.
Serra R; Rizzuto A; Rossi A; Perri P; Barbetta A; Abdalla K; Caroleo S; Longo C; Amantea B; Sammarco G; de Franciscis S
Int Wound J; 2017 Feb; 14(1):149-157. PubMed ID: 26940940
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic Skin Substitutes Versus Human Placental Membrane Products in the Management of Diabetic Foot Ulcers: A Narrative Comparative Evaluation of the Literature.
Luck J; Rodi T; Geierlehner A; Mosahebi A
Int J Low Extrem Wounds; 2019 Mar; 18(1):10-22. PubMed ID: 30663450
[TBL] [Abstract][Full Text] [Related]
16. Active wound coverings: bioengineered skin and dermal substitutes.
Límová M
Surg Clin North Am; 2010 Dec; 90(6):1237-55. PubMed ID: 21074039
[TBL] [Abstract][Full Text] [Related]
17. Simplified noncultured autologous cell grafting for the treatment of chronic nonhealing ulcers: the six-well plate technique.
Seghers AC; Goh BK; Tan SH; Tang BY
Clin Exp Dermatol; 2014 Jul; 39(5):620-3. PubMed ID: 24934915
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis of the Outcomes of Split-Thickness Skin Graft on Diabetic Leg and Foot Ulcers.
Yammine K; Assi C
Int J Low Extrem Wounds; 2019 Mar; 18(1):23-30. PubMed ID: 30841767
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study.
Han SK; Choi KJ; Kim WK
Plast Reconstr Surg; 2004 Dec; 114(7):1783-9. PubMed ID: 15577349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
